Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00358410Phase 2Completed
A Phase 2 trial of casopitant in functional dyspepsia (FD), sponsored by GSK. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00358410.